Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Leaky Scanning02:28

Leaky Scanning

5.2K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.2K
Viral Recombination00:57

Viral Recombination

23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

56
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
56
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

56
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
56

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

RNA Overwriting of Cellular mRNA by Cas13b-Directed RNA-Dependent RNA Polymerase of Influenza A Virus.

International journal of molecular sciences·2023
Same author

RNA Editing with Viral RNA-Dependent RNA Polymerase.

ACS synthetic biology·2022
Same author

Transcription Driven by Reversible Photocontrol of Hyperstable G-Quadruplexes.

ACS synthetic biology·2018
Same author

Duration Control of Protein Expression in Vivo by Light-Mediated Reversible Activation of Translation.

ACS chemical biology·2017
Same author

Reversible Photoregulation of Gene Expression and Translation.

Methods in molecular biology (Clifton, N.J.)·2016
Same author

Control of cellular function by reversible photoregulation of translation.

Chembiochem : a European journal of chemical biology·2014

相关实验视频

Updated: Jul 19, 2025

Generation of Recombinant Influenza Virus from Plasmid DNA
11:31

Generation of Recombinant Influenza Virus from Plasmid DNA

Published on: August 3, 2010

30.9K

复制能力强的流感病毒具有对蛋白质反应的繁殖能力.

Shinzi Ogasawara1

  • 1Department of Biology, Faculty of Science, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano 390-8621, Japan.

New biotechnology
|August 16, 2023
PubMed
概括

研究人员开发了一种用于向病毒治疗的新型流感A病毒 (IAV) 系统. 这种具有复制能力的IAV通过通过纳米体相互作用调节其RNA-依赖RNA聚合酶活性来选择性地准瘤细胞.

科学领域:

  • 病毒学 病毒学
  • 生物技术是生物技术.
  • 基因治疗 基因治疗

背景情况:

  • A型流感病毒 (IAV) 对病毒疗法和生物技术,特别是对复制能力强的菌株,显示出前景.
  • 以特定细胞类型的方式控制IAV复制对于减轻不受控制的感染风险至关重要.

研究的目的:

  • 开发一种简单有效的复制能力强的基于IAV的细胞向系统.
  • 为了能够精确控制针对性治疗应用的IAV乘数.

主要方法:

  • 设计了一个系统来调节IAV核糖核蛋白复合体 (RNP) 的活性.
  • 利用纳米体与依赖RNA的RNA聚合酶 (RdRp) 子单元融合,与内源细胞蛋白相互作用.
  • 使用纳米体对抗p53 (Nb139) 验证了该系统,以控制p53-表达细胞与p53-缺陷细胞中的RNP活性.

主要成果:

  • 证明RNP活性在表达蛋白 (p53) 的细胞中被抑制,在缺乏蛋白的细胞中活跃.
  • 成功生成了一种具有复制能力的IAV,可以在p53缺陷的瘤细胞中选择性地复制.
  • 开发了一种能够以特定细胞类型的方式传递外来基因的IAV载体.

结论:

关键词:
细胞准的目标流感病毒是流感病毒.一个纳米人体.病毒载体病毒载体病毒疗法病毒疗法

更多相关视频

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

8.3K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.3K

相关实验视频

Last Updated: Jul 19, 2025

Generation of Recombinant Influenza Virus from Plasmid DNA
11:31

Generation of Recombinant Influenza Virus from Plasmid DNA

Published on: August 3, 2010

30.9K
Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
08:10

Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses

Published on: January 15, 2020

8.3K
A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
05:21

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection

Published on: August 14, 2019

25.3K
  • 开发的IAV系统为向病毒疗法和生物技术提供了一个灵活的平台.
  • 基于纳米体的调节机制允许轻松适应不同细胞类型的目标.
  • 这种方法为精确和安全的病毒载体应用提供了有价值的工具.